Project
RICE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study
Completed · 2014 until 2018
Müller Rüdiger, Forrer Silvia, Bartz-Batliner Mira, Schmidig Kathrin, Hutz Carina Liane
Type
Range
Units
Status
Start Date
End Date
Financing
Keywords
Brief description/objective
randomisierte Studie bei fortgeschrittener rheumatoider Arthritis mit Certolizumab, Standardtherapie DMARD/Prednison plus Certolizumab vs Therapieeskalation DMARD/Prednison mit Certolizumab und Gelenksinfiltration.